Clinical Trial

Effectiveness of ECP Therapy in Stable Angina Pectoris Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2023 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.
Summary
External Counterpulsation (ECP) is a non-invasive therapy using pressured cuff that is performed on patients with refractory stable angina pectoris to relieve symptoms and increase quality of life. In Indonesia, waiting time for getting coronary artery bypass grafting (CABG) procedure for revascularization treatment in stable angina pectoris patients is way longer than international recommendation which correlates with increase morbidity and mortality during the waiting time. Utilization of ECP for such patients who wait for CABG procedure is still unclear. The investigator aim to evaluate efficacy of addition of ECP compared with medical therapy alone for this population. The efficacy is evaluated using measurement from echocardiography result, treadmill test result, and clinical outcome. if applicable, examination of myocardial perfusion using nuclear examination will also be performed.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-04-29; most recent amendment 2023-09-21.
Status change: Not Yet Recruiting → Recruiting 2023-09-21
Trial Details
NCT Number NCT04873687
Lead Sponsor Universitas Padjadjaran
Conditions Counterpulsation, Angina Pectoris
Enrollment 84 participants
Start Date 2023-07-01
Primary Completion 2024-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2023-09-25